Personalised mRNA cancer vaccines designed uniquely for your pet. Cutting-edge science made accessible and full of hope.
Concept demonstration only. This platform illustrates how personalised mRNA cancer vaccines for pets could potentially work. Not intended for clinical use.
Three simple steps from diagnosis to a treatment designed for your pet.
Tell us about your pet's diagnosis. Upload reports, share details — we handle the complexity.
Our AI analyses the tumour's unique fingerprint and designs a personalised mRNA vaccine for your pet.
Monitor your pet's treatment response with clear, visual dashboards. Celebrate every milestone.
Real product. Real results. Try the demo.

Case management dashboard with pipeline progress tracking

Treatment monitoring — track tumour response in real time

AI-ranked neoantigen candidates for personalised vaccines
Screenshots show demo data for illustration purposes.
The concepts illustrated in this demonstration are informed by published peer-reviewed research in mRNA biology, cancer immunology, and comparative oncology. 46 citations from Nature, Cell, and leading veterinary journals.
Download Scientific Reference DocumentPDF • 46 peer-reviewed citations • For educational reference
This document compiles published peer-reviewed research relevant to the concepts demonstrated. Nomlie itself has not been independently validated or tested. Citations are provided for educational context only. Their inclusion does not constitute endorsement of this platform by any cited author, journal, or institution.
Every step is guided by science, reviewed by experts, and designed with compassion.
Every analysis verified by specialist oncologists and immunologists.
Dogs, cats, and horses. Because every life matters.
Accredited labs and manufacturing partners across Australia.
Track every stage from sample to treatment. No surprises.
Precision immunotherapy tailored to each species' unique biology.
Canine cancer treatment breakthroughs
Feline oncology immunotherapy
Equine cancer care innovation
Be the first to know when Nomlie launches. Get early access.